Research-based life sciences company, Kyowa Kirin Asia Pacific Pte Ltd., a Japan-based, wholly owned subsidiary of Kyowa Hakko Kirin Co Ltd, announced yesterday that it has established an Australian subsidiary, named Kyowa Kirin Australia Pty Ltd (Kyowa Kirin Australia).
With the establishment of Kyowa Kirin Australia, Kyowa Kirin Asia Pacific aims to launch Kyowa Hakko Kirin's global strategic products in the country.
Chikakuni Kotani, president of Kyowa Kirin Asia Pacific said, 'It is our pleasure to announce we have incorporated our subsidiary in Australia. It was announced last month that Kyowa Kirin Group will be shifting to a new global management structure under the 'One Kyowa Kirin' policy. Kyowa Kirin Group will be organised into four regions: North America, EMEA, Asia Pacific and Japan, and business expansion will be accelerated globally. This is Kyowa Kirin Asia Pacific's first entry into Oceania and we are excited about the future possibilities. We believe Kyowa Kirin Australia will contribute to the health and well-being of patients and families in Australia.'1.html
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer